Congenital muscular dystrophy: Clinical and pathologic study of 50 patients with the classical (occidental) merosin-positive form

被引:45
作者
Kobayashi, O
Hayashi, Y
Arahata, K
Ozawa, E
Nonaka, I
机构
[1] National Institute of Neuroscience, Natl. Ctr. of Neurol. and Psychiatry, NCNP, Kodaira, Tokyo
[2] Dept. of Ultrastructural Research, National Institute of Neuroscience, Natl. Ctr. of Neurol. and Psychiatry, Kodaira
关键词
D O I
10.1212/WNL.46.3.815
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We studied 50 patients with the merosin-positive form of congenital muscular dystrophy (MP-CMD) clinically and pathologically. The frequency of MP-CMD in our laboratory was approximately one-half that of the Fukuyama type and one-sixth that of Duchenne muscular dystrophy. The early signs of MP-CMD included decreased fetal movement during pregnancy (14%) and poor suck. (42%), floppiness (30%), and respiratory difficulty (16%) in early infancy. Eighty-six percent of the patients had delayed motor development. Ninety-two percent of the patients followed beyond age 4 years had learned to walk. The disease was relatively slowly progressive, except in six patients who rapidly lost ambulation. Almost all patients had normal IQ, except four who were mildly to moderately retarded. Of the patients examined by cranial CT/MRI, 24% showed cerebral atrophy and 11% had areas of white matter lucency. Muscle biopsy results in those younger than 5 years showed mild dystrophic changes consisting of variation in fiber size and scattered necrotic and regenerating fibers. In older children, there were additional chronic dystrophic changes, including fiber splitting (32%), moth-eaten appearance (32%), marked fatty replacement (46%), and abnormal fiber type distribution (59%). The manifestations of MP-CMD were generally milder and more slowly progressive than those of the Fukuyama type and merosin-negative form of congenital muscular dystrophy.
引用
收藏
页码:815 / 818
页数:4
相关论文
共 18 条
[1]   HYPOXANTHINE AND MCARDLE DISEASE - A CLUE TO METABOLIC STRESS IN THE WORKING FOREARM [J].
BROOKE, MH ;
PATTERSON, VH ;
KAISER, KK .
MUSCLE & NERVE, 1983, 6 (03) :204-206
[2]   THE CLINICAL, GENETIC AND DYSTROPHIN CHARACTERISTICS OF BECKER MUSCULAR-DYSTROPHY .1. NATURAL-HISTORY [J].
BUSHBY, KMD ;
GARDNERMEDWIN, D .
JOURNAL OF NEUROLOGY, 1993, 240 (02) :98-104
[3]  
DUBOWITZ V, 1994, 8 INT C NEUR DIS TOK
[4]  
Dubowitz V., 1985, MUSCLE BIOPSY PRACTI, V2nd, P82
[5]  
FUKUYAMA Y, 1981, BRAIN DEV-JPN, V3, P1
[6]   CONGENITAL MUSCULAR-DYSTROPHY - A CLINICOPATHOLOGIC REPORT OF 24 CASES [J].
MCMENAMIN, JB ;
BECKER, LE ;
MURPHY, EG .
JOURNAL OF PEDIATRICS, 1982, 100 (05) :692-697
[7]   EXPRESSION OF UTROPHIN (DYSTROPHIN-RELATED PROTEIN) AND DYSTROPHIN-ASSOCIATED GLYCOPROTEINS IN MUSCLES FROM PATIENTS WITH DUCHENNE MUSCULAR-DYSTROPHY [J].
MIZUNO, Y ;
YOSHIDA, M ;
NONAKA, I ;
HIRAI, S ;
OZAWA, E .
MUSCLE & NERVE, 1994, 17 (02) :206-216
[8]   THE SIGNIFICANCE OF TYPE-2C MUSCLE-FIBERS IN DUCHENNE MUSCULAR-DYSTROPHY [J].
NONAKA, I ;
TAKAGI, A ;
SUGITA, H .
MUSCLE & NERVE, 1981, 4 (04) :326-333
[9]   MUSCLE HISTOCHEMISTRY IN CONGENITAL MUSCULAR-DYSTROPHY WITH CENTRAL NERVOUS-SYSTEM INVOLVEMENT [J].
NONAKA, I ;
SUGITA, H ;
TAKADA, K ;
KUMAGAI, K .
MUSCLE & NERVE, 1982, 5 (02) :102-106
[10]  
NONAKA I, 1979, HDB CLIN NEUROLOGY, V41, P27